Subcutaneous Lidocaine For Cancer-Related Pain

NCT01384877 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Cancer-related Pain

Interventions

DRUG: Lidocaine
DRUG: Placebo (D5W)

Sponsor

British Columbia Cancer Agency

Collaborators

[object Object]